Savira pharmaceuticals

Last updated: 13.02.2014

Address: Veterinärplatz 1, Building IA, 1210 Vienna,Austria

Tel: +43-1-25077-5904


Company description

Savira pharmaceuticals – located in Vienna, Austria – is focusing on the development of drugs for the treatment of influenza. Based on know-how and intellectual property from its co-founders, the European Molecular Biology Laboratory (EMBL) and the Vienna-based biotech company onepharm Research and Development GmbH, Savira will manage a focused portfolio of medicinal chemistry programs aiming at the identification of lead candidates and the development of efficacious and selective anti-influenza drugs.

Products and services

Savira follows the biotech business model, turning capital and public grants into the preclinical and clinical development of a portfolio of anti-influenza drug candidates. Savira thus strives to create a sustainable pipeline, generate value for shareholders, improve quality of life for people suffering from influenza, and add to the arsenal of antivirals thus improving influenza pandemic preparedness.
Savira was founded by the EMBL, onepharm, private investors, and Savira‘s management team.



We use cookies to ensure that we give you the best experience on our site. For more info click here